Eli Lilly and Company (NYSE: LLY) will announce its third-quarter 2024 financial results on Oct. 30, 2024. Lilly will also conduct a conference call that day with the investment community and ...

Earnings Report 1.454 USD Q3 2024 Earnings Release 10/30/2024 Earnings Report 5.436 USD Q4 2024 Earnings Release 01/30/2025 Earnings Report 5.367 USD Q1 2025 Earnings Release 04/24/2025 Earnings ...

Eli Lilly is making a series of investments in China to support its manufacturing and R&D operations. Gilead Sciences has abandoned a liver disease collaboration with Yuhan. A new study suggests ...

Explore reporting grant announcements, K-12 program and Campus Consortium updates, webinar recordings, archived newsletters, and more! Visit the newsletter archive for our weekly messages to the ...

Shares of Eli Lilly have gained considerably throughout 2024, thanks in large part to the company's success in diabetes and obesity care. Outside of weight loss, Eli Lilly has a major opportunity ...

Upgrade to begin using 40 years of financial statements and get so much more. Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all ...

In 2021, Li’s team conducted a double-blind trial where neither the patients nor the clinicians knew whether they were using the laser or sham treatment. They found no meaningful difference ...